✦ LIBER ✦

Recent advances in sex therapy: Integration with the dynamic therapies

✍ Scribed by Alexander N. Levay; Arlene Kagle

Publisher: Springer US
Year: 1978
Tongue: English
Weight: 767 KB
Volume: 50
Category: Article
ISSN: 0033-2720
DOI: 10.1007/bf01064774

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Germ cell tumors of the CNS in children:

Germ cell tumors of the CNS in children: recent advances in therapy

✍ Blanca Diez; Casilda Balmaceda; Matsao Matsutani; H. L. Weiner 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 49 KB

Recent advances in understanding the cel

Recent advances in understanding the cell death pathways activated by anticancer therapy

✍ Ryungsa Kim 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

Recent Advances in Laser Therapy for the

Recent Advances in Laser Therapy for the Treatment of Cutaneous Vascular Disorders

✍ W.J. Loo; S.W. Lanigan 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 48 KB

Stem cells in liver diseases and cancer:

Stem cells in liver diseases and cancer: Recent advances on the path to new therapies

✍ C. Bart Rountree; Lopa Mishra; Holger Willenbring 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

L-asparaginase therapy in children with

L-asparaginase therapy in children with advanced leukemia The Southwest cancer chemotherapy study group

✍ Wataru W. Sutow; Florentina Garcia; Kenneth A. Starling; Thomas E. Williams; Dan 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Neck dissection in the combined-modality

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

✍ Athanassios Argiris; Kerstin M. Stenson; Bruce E. Brockstein; Bharat B. Mittal; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## Abstract ## Purpose. The purpose of this study was to evaluate the role of neck lymph node (ND) in the combined dissection modality therapy for locoregionally advanced head and neck. ## Methods. We identified patients with N2–N3 head and neck cancers who were enrolled in three consecutive mul